Other MEDICAL sector stocks have related patterns, especially in last 6 months. ABT is one, but MDT (MedTronic) seems to me to be in very similar muliti-year situation despite increased earnings and revenues.
JNJ price was last so low in 2021.
From the fundamentals, it sure appears this stock is oversold, or perhaps there are factors hanging over this sector that I have not come to appreciate.
JNJ pays a respectable if not exciting dividend, as does MDT.
As several Motley Fool authors have recently written, these are companies to buy and to hold, seems like the next few years, and 2025especially is set up for some nice price appreciation, but when it will kick in is the question, the chart without historical context, does not look good.